author-photo

Janusz Lange

37

Papers

134

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

CD14 + HLADR - blood values in patients after alloHSCT are highly predictive of survival and infectious complications.

2021 Transplant Immunology
Show All
- Source
- Cite
- Save
Citations (1)
Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Regeneration of the immune system to fight leukemia at relapse post alloHSCT

2020
Show All
- Source
- Cite
- Save
Citations (0)
INTRA-BONE DLI AT RELAPSE AFTER ALLO-HSCT IMPROVES SURVIVAL WITH LOWERING OF PD-1 POSITIVITY OF CD8+ CELLS AND PRESERVATION OF THE PROFILE OF TCR BETA DOMINANT CLONES IN THE MARROW: PS1217

2019
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of CNV in the Genomes of the Marrow Cells of the Patients with AML Revealed That High Numbers of Aberrations Associate with Better Survival and Deletions with the Aberrant Expression of CD19 in the Leukemic Blasts

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow

2019 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Fifteen-year follow-up of patients with critical limb ischaemia after local cellular therapy: the long-term positive effect is due to the presence of CD45– CD34– and CD34+ cells in the inoculum

2019 Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (0)
The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow

2018 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (11)
Microdeletion in Chromosome 17 Cytoband q21.31 Identified As Located within the KANSL1 Gene Prevailed in Flt3-ITD Negative Normal Karyotype AML Patients As Opposed to Their AML Counterparts and Influenced the Phenotype of the Disease

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
„License to kill” – hamujące receptory KIR mogą zwiększać zdolność komórek NK do niszczenia komórek nowotworu w odpowiednim środowisku HLA klasy I u biorców przeszczepu krwiotwórczych komórek macierzystych

2015 Acta haematologica Polonica
Show All
- Source
- Cite
- Save
Citations (0)